Bristol-Myers Squibb was founded in 1858 and has grown ... we made in the U.S. strengthen our confidence as we build a solid foundation for future growth. We will continue to invest the necessary ...

Bristol Myers Squibb won the dismissal of a proposed class action accusing it of fraudulently obtaining patents and filing ...

With data as of April 9, 2025, we examine if Bristol-Myers Squibb Company(BMY) is consistently building momentum based on ...

With a market cap of $102.7 billion, Bristol-Myers Squibb Company (BMY) is a leading global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines for ...

Find out how Bristol Myers Squibb was honored for 50 years of service in Lawrence, from local support to global medical ...

Vandana Singh Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies Even as Donald Trump paused the reciprocal tariffs ...

A federal appeals court on Tuesday affirmed the dismissal of a dental surgeon’s suit alleging Bristol-Myers Squibb Co.'s leukemia drug Sprycel caused retinal bleeding and vision loss.

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other profitable dividend stocks. Amid growing concerns about economic growth and ...

In this article, we are going to take a look at where Bristol-Myers Squibb Co. (NYSE:BMY) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading week ...

Bristol Myers Squibb pays investors a very attractive dividend that yields 4.1%. The company reported a loss last year, but that was a result of non-recurring expenses. Free cash flow looked ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Sell rating on Bristol-Myers Squibb (BMY – Research Report), with a ...